Zydus Lifesciences shines on reporting 30% rise in Q3 consolidated net profit

06 Feb 2025 Evaluate

Zydus Lifesciences is currently trading at Rs. 1002.10, up by 23.85 points or 2.44% from its previous closing of Rs. 978.25 on the BSE.

The scrip opened at Rs. 986.85 and has touched a high and low of Rs. 1003.20 and Rs. 976.20 respectively. So far 9981 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1323.90 on 09-Aug-2024 and a 52 week low of Rs. 769.10 on 09-Feb-2024.

Last one week high and low of the scrip stood at Rs. 1003.20 and Rs. 945.00 respectively. The current market cap of the company is Rs. 98434.84 crore.

The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 18.18% and 6.84% respectively.

Zydus Lifesciences has reported 4.49% rise in its net profit at Rs 470.6 crore for Q3FY25 as compared to Rs 450.4 crore for the same quarter in the previous year. Total income of the company increased by 4.65% at Rs 2593.4 crore for Q3FY25 as compared to Rs 2478.1 crore for the corresponding quarter previous year. 

On consolidated basis, the company has reported 29.62% rise in its net profit at Rs 1023.5 crore for the quarter ended December 31, 2024 as compared to Rs 789.6 crore for the same quarter in the previous year. Total income of the company increased by 17.25% at Rs 5326.6 crore for Q3FY25 as compared to Rs 4542.9 crore for the corresponding quarter previous year.


Zydus Lifesciences Share Price

910.50 9.20 (1.02%)
31-Dec-2025 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.30
Dr. Reddys Lab 1262.05
Cipla 1494.40
Zydus Lifesciences 910.50
Lupin 2083.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×